{
    "2019-09-23": [
        [
            {
                "time": "",
                "original_text": "研发一哥百济神州遭质疑：去年研发支出48亿远超同行",
                "features": {
                    "keywords": [
                        "百济神州",
                        "研发支出",
                        "质疑",
                        "同行对比"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-09-23",
                "original_text": "格隆汇个股放量排行榜 | 9月23日",
                "features": {
                    "keywords": [
                        "个股放量",
                        "排行榜"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "议事厅丨复星医药业绩承压，上半年50亿销售费用侵蚀利润，“医药界PE”下一步该如何破局？ 盈利能力下降",
                "features": {
                    "keywords": [
                        "复星医药",
                        "销售费用",
                        "侵蚀利润",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "4+7带量采购中标结果明日出炉，中国中药挫逾5%领跌医药股",
                "features": {
                    "keywords": [
                        "4+7带量采购",
                        "中标结果",
                        "中国中药",
                        "领跌医药股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-16至2019-09-22",
                "original_text": "消费+科技属性将驱动医药长牛 —— 医药行业周报（2019.09.16-2019.09.22）",
                "features": {
                    "keywords": [
                        "消费+科技",
                        "医药长牛",
                        "行业周报"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[中信建投医药|行业周报] 新旧交替机会不断 配置高性价比标的",
                "features": {
                    "keywords": [
                        "中信建投",
                        "行业周报",
                        "新旧交替",
                        "高性价比标的"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 我国迎来首仿药上市热潮, 建议关注相关优质企业",
                "features": {
                    "keywords": [
                        "医药行业",
                        "首仿药",
                        "上市热潮",
                        "优质企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}